KBC Group NV Grows Position in Kenvue Inc. $KVUE

KBC Group NV increased its stake in shares of Kenvue Inc. (NYSE:KVUE) by 98.3% in the first quarter, Holdings Channel.com reports. The fund owned 977,811 shares of the company’s stock after purchasing an additional 484,695 shares during the period. KBC Group NV’s holdings in Kenvue were worth $16,858,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of KVUE. SEB Asset Management AB bought a new stake in Kenvue in the 1st quarter valued at $7,549,000. Swiss National Bank grew its position in shares of Kenvue by 6.9% during the first quarter. Swiss National Bank now owns 5,622,946 shares of the company’s stock valued at $96,940,000 after purchasing an additional 364,000 shares in the last quarter. Mediolanum International Funds Ltd purchased a new position in shares of Kenvue during the first quarter valued at about $270,000. Ceera Investments LLC increased its holdings in shares of Kenvue by 4.4% in the first quarter. Ceera Investments LLC now owns 156,874 shares of the company’s stock worth $2,705,000 after purchasing an additional 6,625 shares during the last quarter. Finally, Heartland Bank & Trust Co increased its holdings in shares of Kenvue by 9.2% in the first quarter. Heartland Bank & Trust Co now owns 12,261 shares of the company’s stock worth $211,000 after purchasing an additional 1,037 shares during the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts recently commented on KVUE shares. Barclays increased their price target on Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research note on Tuesday. Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Zacks Research downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. Citigroup cut their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Finally, Wall Street Zen raised shares of Kenvue to a “buy” rating in a research note on Sunday, July 12th. Three research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $19.58.

Insiders Place Their Bets

In other news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a filing with the SEC, which is available at this link. 1.59% of the stock is owned by company insiders.

Kenvue Trading Down 0.2%

Shares of KVUE stock opened at $18.98 on Wednesday. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $22.87. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. The stock’s 50 day simple moving average is $18.26 and its two-hundred day simple moving average is $17.88. The company has a market cap of $36.43 billion, a PE ratio of 22.32, a price-to-earnings-growth ratio of 1.44 and a beta of 0.47.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $3.84 billion. During the same period last year, the company earned $0.24 EPS. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. Research analysts predict that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were given a dividend of $0.2075 per share. The ex-dividend date was Wednesday, May 13th. This represents a $0.83 dividend on an annualized basis and a yield of 4.4%. Kenvue’s payout ratio is 97.65%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.